Laporan Kasus : Pubertas Dini Akibat Kanker Ovarium Tipe Embrional

Authors

  • Subandi Reksohusodo Fakultas Kedokteran Universitas Brawijaya

DOI:

https://doi.org/10.21776/ub.JOIM.2021.005.01.5

Keywords:

Keywords, embryonal carcinoma, embryonal ovarian carcinoma

Abstract

Embryonic carcinoma (EC) cells were the first pluripotent cells identified. These cells were derived from malignant germ cell tumors called teratocarcinomas. Embryonal carcinoma also affects young patients but is far less common than yolk sac tumor in the ovary and, when encountered, is always a component of a mixed germ cell tumor.1 Malignant germ cell tumors are subdivided into dysgerminoma and nondygerminomatous tumors. The most common types of nondysgerminomatous tumors are yolk sac and immature teratoma. Mixed germ cell tumors with embryonal carcinoma, nongestational choriocarcinoma, and polyembryoma are less common. Embryonal carcinomas, though rare, are one of the most malignant cancers arising in the ovary.2In this case report, a 4,5-year-old girl was diagnosed with suspected embryonal ovarian carcinoma after complaints having menstruation for three months, develop pubic hair and breast. This patients later had laparotomy surgical staging and undergoing chemotherapy. 

Author Biography

Subandi Reksohusodo, Fakultas Kedokteran Universitas Brawijaya

Fakultas Kedokteran Universitas Brawijaya

References

Embryonal Carcinoma - an overview | ScienceDirect Topics [Internet]. [cited 2020 Oct 6]. Available from: https://www.sciencedirect.com/topics/medicine-and-dentistry/embryonal-carcinoma

Moniaga NC, Randall LM. Malignant Mixed Ovarian Germ Cell Tumor with Embryonal Component. J Pediatr Adolesc Gynecol. 2011 Feb 1;24(1):e1.

Vega-Naredo I, Loureiro R, Mesquita KA, Barbosa IA, Tavares LC, Branco AF, et al. Mitochondrial metabolism directs stemness and differentiation in P19 embryonal carcinoma stem cells. Cell Death Differ [Internet]. 2014 Oct 1 [cited 2020 Oct 7];21(10):1560–74. Available from: www.nature.com/cdd

Poynter JN, Amatruda JF, Ross JA. Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006. Cancer [Internet]. 2010 Oct 15 [cited 2020 Oct 7];116(20):4882–91. Available from: http://doi.wiley.com/10.1002/cncr.25454

Medeiros F, Strickland KC. Chapter 26 - Germ Cell Tumors of the Ovary. In: Diagnostic Gynecologic and Obstetric Pathology. Elsevier; 2017. p. 949–1010.

Katz V, Lentz G, Gynecology RL-, Elsevier 5th ed. Philadelphia: Mosby, 2007 undefined. Neoplastic diseases of the ovary.

Sternberg’s Diagnostic Surgical Pathology - Stacey E. Mills - Google Buku [Internet]. [cited 2020 Oct 7]. Available from: https://books.google.co.id/books?id=qm7xxwEACAAJ&dq=isbn:9780781779425&hl=id&sa=X&ved=2ahUKEwj1zOGT06HsAhVMAHIKHUcgB1kQ6AEwAHoECAAQAg

Robbins and Cotran Review of Pathology - 4th Edition [Internet]. [cited 2020 Oct 7]. p. 300. Available from: https://www.elsevier.com/books/robbins-and-cotran-review-of-pathology/klatt/978-1-4557-5155-6

Matei D, Brown J, Frazier L. Updates in the Management of Ovarian Germ Cell Tumors. Am Soc Clin Oncol Educ B [Internet]. 2013 May 16 [cited 2020 Oct 7];(33):e210–6. Available from: http://ascopubs.org/doi/10.14694/EdBook_AM.2013.33.e210

Bailey J, Church D. Management of germ cell tumours of the ovary. Rev Gynaecol Pract. 2005 Dec;5(4):201–6.

Malignant Mixed Ovarian Germ Cell Tumor with Embryonal Component - ScienceDirect [Internet]. [cited 2020 Oct 6]. Available from: https://www.sciencedirect.com/science/article/pii/S1083318810001737?casa_token=HNsNatxsSPMAAAAA:ACS3eCz6mHZfz5mW86U2t6hXvW6lRayOavHpDUDwWMutTFTmtvT4Rn4mQEMY5nsGG2RvQTtIdT0

Weinberg LE, Lurain JR, Singh DK, Schink JC. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors. Gynecol Oncol [Internet]. 2011 May 1 [cited 2020 Oct 7];121(2):285–9. Available from: https://pubmed.ncbi.nlm.nih.gov/21256579/

Gershenson DM. Management of ovarian germ cell tumors. Vol. 25, Journal of Clinical Oncology. American Society of Clinical Oncology; 2007. p. 2938–43.

Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA, et al. Surveillance after initial surgery for pediatric and adolescent girls with stadium I ovarian germ cell tumors: Report from the children’s oncology group. J Clin Oncol [Internet]. 2014 Feb 10 [cited 2020 Oct 7];32(5):465–70. Available from: http://ascopubs.org/doi/10.1200/JCO.2013.51.1006

Billmire DF, Vinocur C, Rescorla F, Cushing B, London W, Schlatter M, et al. Outcome and Staging Evaluation in Malignant Germ Cell Tumors of the Ovary in Children and Adolescents: An Intergroup Study. In: Journal of Pediatric Surgery [Internet]. W.B. Saunders; 2004 [cited 2020 Oct 7]. p. 424–9. Available from: https://pubmed.ncbi.nlm.nih.gov/15017564/

Mead GM. International germ cell consensus classification: A prognostic factor- based staging system for metastatic germ cell cancers. J Clin Oncol. 1997 Sep 21;15(2):594–603.

Palenzuela G, Martin E, Meunier A, Beuzeboc P, Laurence V, Orbach D, et al. Comprehensive Staging Allows for Excellent Outcome in Patients With Localized Malignant Germ Cell Tumor of the Ovary. Ann Surg [Internet]. 2008 Nov [cited 2020 Oct 8];248(5):836–41. Available from: http://journals.lww.com/00000658-200811000-00020

Downloads

Published

2021-05-08

Issue

Section

Articles